Daniel Peckham Selected Research

Piperacillin

1/2018	β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells.
12/2017	Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts.
6/2013	β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
8/2012	Nonimmediate β-lactam reactions in patients with cystic fibrosis.
6/2012	Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.
7/2011	Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Peckham Research Topics

Disease

19	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 12/2003
8	Infections 01/2021 - 08/2011
8	Hypersensitivity (Allergy) 01/2018 - 06/2010
3	Allergic Bronchopulmonary Aspergillosis 06/2019 - 11/2008
3	Inflammation (Inflammations) 01/2019 - 04/2018
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Exocrine Pancreatic Insufficiency 01/2022 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2020 - 01/2019
1	Meconium Ileus 01/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 10/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Disease Progression 01/2020
1	Asthma (Bronchial Asthma) 06/2019
1	Bronchitis 06/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Lung Diseases (Lung Disease) 04/2018
1	Immune System Diseases (Immune Disorders) 04/2018
1	Myocardial Infarction 06/2013
1	Drug Hypersensitivity (Drug Allergy) 08/2012
1	Amenorrhea 06/2010
1	Pseudomonas Infections 02/2008
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 02/2002

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2008
7	Pharmaceutical PreparationsIBA 10/2021 - 06/2010
7	AntigensIBA 06/2019 - 06/2010
6	LactamsIBA 01/2018 - 06/2012
6	Piperacillin FDA LinkGeneric 01/2018 - 07/2011
3	InflammasomesIBA 01/2021 - 01/2017
3	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2020 - 01/2019
3	Immunoglobulin G (IgG)IBA 06/2019 - 11/2008
2	AntibodiesIBA 06/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2011
2	HaptensIBA 01/2017 - 08/2012
2	Sulfamethoxazole FDA LinkGeneric 06/2011 - 06/2010
1	Proton Pump InhibitorsIBA 01/2022
1	elexacaftorIBA 01/2022
1	ivacaftor drug combination tezacaftorIBA 01/2022
1	Cysteamine (Mercaptamine)FDA Link 01/2020
1	Recombinant ProteinsIBA 06/2019
1	Immunoglobulin E (IgE)IBA 06/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	ChloridesIBA 01/2019
1	ElectrolytesIBA 01/2019
1	Ribonucleases (Ribonuclease)IBA 01/2019
1	SodiumIBA 01/2019
1	Epithelial Sodium ChannelsIBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2018
1	Interleukin-18 (Interleukin 18)IBA 04/2018
1	MacrolidesIBA 04/2018
1	Penicillins (Penicillin)FDA Link 12/2017
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2017
1	PyrinIBA 01/2017
1	AerosolsIBA 11/2016
1	Aztreonam FDA LinkGeneric 06/2013
1	Human Serum Albumin FDA LinkGeneric 06/2013
1	Meropenem (Merrem)FDA LinkGeneric 06/2013
1	AlbuminsIBA 06/2013
1	A 19IBA 06/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2011
1	Deoxyribonucleases (DNase)FDA Link 08/2011
1	Interleukin-17 (Interleukin 17)IBA 06/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	EnzymesIBA 06/2011
1	Interleukin-10 (Interleukin 10)IBA 06/2011
1	SulfonamidesIBA 06/2011
1	dornase alfa (Pulmozyme)FDA Link 01/2011
1	Colistin (Coly-Mycin)FDA Link 12/2003
1	Vitamin K FDA Link 02/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2008
1	Transplantation 01/2022
1	Nursing Care 01/2020
1	Aftercare (After-Treatment) 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Biological Therapy 04/2018
1	Length of Stay 08/2011
1	Nebulizers and Vaporizers (Inhaler) 08/2011
1	Ventriculostomy 06/2010
1	Intravenous Administration 12/2003